Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis

Area of Science:

• Genomics
• Molecular Biology
• Cardiovascular Research

Background:

• Dilated cardiomyopathy (DCM) is a significant cause of heart failure with high mortality.
• Understanding the molecular mechanisms underlying DCM is crucial for developing effective treatments.

Purpose of the Study:

• To investigate potential microRNA (miRNA)-messenger RNA (mRNA) interactions in DCM.
• To identify novel drug candidates for DCM therapy.

Main Methods:

• Bioinformatic analysis of Gene Expression Omnibus (GEO) microarray data.
• Construction of miRNA-mRNA regulatory networks using miRWalk 2.0 and Cytoscape.
• Pathway and Gene Ontology enrichment analysis via KOBAS.
• Drug target prediction using the Drug Signatures Database (DSigDB).

Main Results:

• Identified 8 differentially expressed miRNAs and 92 differentially expressed mRNAs.
• Uncovered 47 differentially expressed miRNA target genes.
• Highlighted 6 hub genes (hsa-miR-551b-3p, hsa-miR-770-5p, hsa-miR-363-3p, PIK3R1, DDIT4, CXCR4) potentially involved in DCM pathogenesis.
• Predicted several candidate drugs associated with these hub genes.

Conclusions:

• The study identified key molecular players in DCM pathogenesis.
• The identified hub genes and associated drugs represent potential therapeutic targets for clinical intervention in DCM.